TRAP1 and ovarian carcinoma: The biological relevance of this observation is unclear, even though it is consistent with recent data showing that selected human malignancies (i.e., ovarian, cervical and renal carcinomas) are characterized by low TRAP1 expression [17] and that TRAP1 downregulation induces activation of oxidative metabolism and cisplatin resistance in ovarian carcinoma [30].